The global pharmaceutical industry experienced a 6% rise in new job postings related to corporate governance in Q3 2022 compared with the previous quarter, according to GlobalData’s whitepaper on Corporate Governance in Pharmaceutical – Hiring Activity in Q3 2022. This compares to a 21% increase versus Q3 2021.
Notably, Registered Nurses jobs accounted for a 14% share of the global pharmaceutical industry’s corporate governance-related total new job postings in Q3 2022, up 0.56% over the prior quarter.
Registered Nurses, with a share of 14%, emerged as the top corporate governance-related job roles within the pharmaceutical industry in Q3 2022, with new job postings rising by 0.56% quarter-on-quarter. General and Operations Managers came in second with a share of 5% in Q3 2022, with new job postings rise by 3% over the previous quarter.
The other prominent corporate governance roles include Therapists with a 2% share in Q3 2022, Physicians with a 2% share of new job postings.
The top companies, in terms of number of new job postings tracked by GlobalData, as of Q3 2022 were Vancouver Coastal Health, Bristol-Myers Squibb, Baylor Scott & White Health and SSM DePaul Health Center. Together they accounted for a combined share of 17% of all corporate governance-related active jobs in the pharmaceutical industry.
Vancouver Coastal Health posted 2,113 jobs in Q3 2022 and registered a rise of 2% over the previous quarter, followed by Bristol-Myers Squibb with 1,486 jobs and a 5% drop. Baylor Scott & White Health with 1,112 jobs and SSM DePaul Health Center with 794 jobs, recorded a 23% growth and a 73% increase, respectively, while Intermountain Healthcare recorded a 103% increase with 770 job postings during Q3 2022.
The largest share of corporate governance-related new job postings in the pharmaceutical industry in Q3 2022 was in the US with 75% followed by Canada (10%) and Australia (2%). The share represented by the US was four percentage points higher than the 71% share it accounted for in Q2 2022.